Загрузка...
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
Background: Febrile neutropenia (FN) remains one of the most challenging problems in medical oncology and is a very severe side effect of chemotherapy. Its late consequences, when it is recurrent or of a severe grade, are dose reduction and therapy delays. Current guidelines allow the administration...
Сохранить в:
| Опубликовано в: : | Medicina (Kaunas) |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8305666/ https://ncbi.nlm.nih.gov/pubmed/34208815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57070675 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|